ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Incorporated (LGND)

99.985
-1.37
( -1.35% )
Updated: 09:49:09

Income Statement

Balance Sheet

Cash Flow

Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 66.09M27.05M43.98M26.37M34.99M28.1M30.98M41.53M
Operating Income 636k12.18M14.21M-1.98M3.08M-3.36M2.99M-19.1M
Pre Tax Income 857k55.93M55.54M3.17M-12.14M17.1M113.45M-65.39M
Net Income 404k-17.49M41.95M2.29M-10.27M18.19M86.14M-51.91M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT 1.52M10.9M14.81M-2.86M-1.22M1.38M600k-48.33M
EBITDA 13.92M9.81M23.7M24.59M-4.47M4.63M11.75M16.24M
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 108.97M141.1M251.45M120.28M186.42M314.73M196.25M131.31M
Operating Income 40.55M66.03M213.91M-5.72M8.73M78.9M3.04M9.82M
Pre Tax Income 7.96M57.23M173.33M796.64M-10.54M47.3M36.01M63.66M
Net Income -1.64M12.56M143.32M629.3M-2.99M57.14M-33.36M52.15M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -0.0780.5946.90237.407-0.1863.408-1.9682.991
EBIT 20.14M68.63M207.61M801.07M25.74M70.04M7.22M9.99M
EBITDA 51.39M78.55M230.61M38.01M36.25M129.96M41.07M46.34M